Trimetazidine impurity 6

Trimetazidine impurity 6 is a chemical byproduct associated with the synthesis of Trimetazidine, a medication used primarily in the treatment of angina pectoris. This impurity serves as an important reference standard in pharmaceutical research and quality control, aiding in the assessment of Trimetazidine’s purity and safety. Its identification and analysis are crucial for ensuring compliance with regulatory standards in drug development.